Don’t miss – Page 10 – Endpoints News

SUBSCRIBE

Acadia declares early win on Nuplazid dementia study, stunning analysts and sending shares soaring

3 months ago

Tony Coles sets sail on new neuro pursuit at Cerevel, steering Pfizer spinout as CEO

3 months ago

Eli Lilly hustles up an impressive set of pivotal data for their $8B Loxo drug — as rival nips at their heels

3 months ago

MIT’s star tech guru Joi Ito resigns biotech chair post in wake of Jeffrey Epstein scandal

3 months ago

A strong performance by AMG510 stokes fresh enthusiasm on the future of Amgen's landmark KRAS G12C program — but shares slide

3 months ago

Genentech reaches settlement with Taiwanese biotech accused of stealing trade secrets — but will keep suing ex-staffers

3 months ago

Roivant's Vivek Ramaswamy is closing in on a $3B cash deal to sell control of 5 Vants — plus — to Sumitomo Dainippon

3 months ago

How much has the cancer R&D frenzy translated into drug approvals? A lot

3 months ago

The IFM team sets up a three-peat as Novartis funds cGAS/STING program — with $840M option to buy

3 months ago

The pharma industry's rep hits absolute. rock. bottom.

3 months ago

Ex-FDA chiefs, non-profits take Ned Sharpless' corner as clock ticks down on Trump's pick

3 months ago

George Scangos heads back to Wall Street. And he’s bringing along some of the best connections in biotech

3 months ago

In the midst of a deal spree, Bayer turns to veteran J&J dealmaker Marianne De Backer to bring home the technology

3 months ago

Ardelyx's lead drug tenapanor scores in second hyperphosphatemia study, shares leap

3 months ago

Vertex gambles $950M on biotech buyout, hunting a cure for diabetes

3 months ago

RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies

3 months ago

A new PCSK9 player draws rave reviews for inclisiran. Can a marketing war with Amgen be far behind?

3 months ago

Alexion hit by surprise inter partes review as Amgen challenges Soliris patents

3 months ago

Remember that post-marketing trial? New study confirms many drugmakers don’t do them — half drag their feet

3 months ago

Novartis preps a 2020 launch in multiple sclerosis as 2 successful pivotal trials set stage for an assault on Roche’s new star franchise

3 months ago

AbbVie’s $10B Rova-T play ends in one last failure — R&D team shuts it all down

3 months ago

Amgen’s legendary lawyer corps loses a major court fight attempting to quash PCSK9 rival from Sanofi, Regeneron

3 months ago

Tears for FAERS: Another FAERS disaster rumor slams Vertex shares in a Wall Street melee — but this time the tempest passed quickly

3 months ago

The Woodford effect: Teetering on the edge, his co-investors are feeling the pain — and they want it to stop

3 months ago

First page Previous page 7 8 91011 12 13 Next page Last page